Literature DB >> 12023948

'Entourage' effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism.

Darren Smart1, Kent-Olov Jonsson, Séverine Vandevoorde, Didier M Lambert, Christopher J Fowler.   

Abstract

1. The abilities of a series of saturated N-acyl ethanolamines and related compounds to affect the ability of anandamide (AEA) to produce a Ca2+ influx into human embryonic kidney cells expressing the human vanilloid receptor (hVR1-HEK293 cells) has been investigated. 2. The C3:0, C4:0, C6:0 and C10:0 ethanolamides neither affected basal Ca2+-influx, nor the influx in response to a submaximal concentration of AEA (1 microM). In contrast, the C12:0, C17:0, C18:0 ethanolamides and the monounsaturated compound oleoylethanolamide (C18:1) greatly potentiated the response to AEA. Palmitoylethanolamide (C16:0) produced both a response per se and an augmentation of the response to AEA. 3. Lauroylethanolamide (C12:0) produced a leftward shift in the dose-response curve for AEA. EC50 values for AEA to produce Ca2+ influx into hVR1-HEK293 cells were 1.8, 1.5, 1.1 and 0.22 microM in the presence of 0, 1, 3 and 10 microM lauroylethanolamide, respectively. Lauroylethanolamide did not affect the dose - response curves to capsaicin. 4. Palmitoylethylamide was synthesized and found to be a mixed-type inhibitor (K(i(slope)) 4.1 microM, K(i(intercept)) 66 microM) of [3H]-AEA metabolism by rat brain membranes. 5. The -amide, -ethylamide, -isopropylamide, -butylamide, -cyclohexamide and -trifluoromethyl ketone analogues of palmitoylethanolamide had little or no effect on the Ca2+ influx response to 1 microM AEA. 6. There was no obvious relation between the abilities of the compounds to enhance the Ca2+ influx response to 1 microM AEA into hVR1-HEK293 cells and to prevent the hydrolysis of AEA by rat brain membranes. 7. It is concluded that although palmitoylethanolamide has entourage-like effects at VR1 receptors expressed on hVR1-HEK293 cells, other N-acyl ethanolamines have even more dramatic potentiating effects. It is possible that they may play an important role under conditions where their synthesis is increased, such as in severe inflammation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12023948      PMCID: PMC1573364          DOI: 10.1038/sj.bjp.0704732

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  34 in total

1.  The capsaicin receptor: a heat-activated ion channel in the pain pathway.

Authors:  M J Caterina; M A Schumacher; M Tominaga; T A Rosen; J D Levine; D Julius
Journal:  Nature       Date:  1997-10-23       Impact factor: 49.962

2.  Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides.

Authors:  B F Cravatt; D K Giang; S P Mayfield; D L Boger; R A Lerner; N B Gilula
Journal:  Nature       Date:  1996-11-07       Impact factor: 49.962

3.  Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide.

Authors:  P M Zygmunt; J Petersson; D A Andersson; H Chuang; M Sørgård; V Di Marzo; D Julius; E D Högestätt
Journal:  Nature       Date:  1999-07-29       Impact factor: 49.962

4.  Ibuprofen inhibits rat brain deamidation of anandamide at pharmacologically relevant concentrations. Mode of inhibition and structure-activity relationship.

Authors:  C J Fowler; G Tiger; A Stenström
Journal:  J Pharmacol Exp Ther       Date:  1997-11       Impact factor: 4.030

5.  Molecular characterization of human and mouse fatty acid amide hydrolases.

Authors:  D K Giang; B F Cravatt
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

6.  An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity.

Authors:  S Ben-Shabat; E Fride; T Sheskin; T Tamiri; M H Rhee; Z Vogel; T Bisogno; L De Petrocellis; V Di Marzo; R Mechoulam
Journal:  Eur J Pharmacol       Date:  1998-07-17       Impact factor: 4.432

7.  Capsaicin binds to the intracellular domain of the capsaicin-activated ion channel.

Authors:  J Jung; S W Hwang; J Kwak; S Y Lee; C J Kang; W B Kim; D Kim; U Oh
Journal:  J Neurosci       Date:  1999-01-15       Impact factor: 6.167

8.  Isolation and structure of a brain constituent that binds to the cannabinoid receptor.

Authors:  W A Devane; L Hanus; A Breuer; R G Pertwee; L A Stevenson; G Griffin; D Gibson; A Mandelbaum; A Etinger; R Mechoulam
Journal:  Science       Date:  1992-12-18       Impact factor: 47.728

9.  Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist.

Authors:  D G Deutsch; S A Chin
Journal:  Biochem Pharmacol       Date:  1993-09-01       Impact factor: 5.858

10.  Accumulation of various N-acylethanolamines including N-arachidonoylethanolamine (anandamide) in cadmium chloride-administered rat testis.

Authors:  S Kondo; T Sugiura; T Kodaka; N Kudo; K Waku; A Tokumura
Journal:  Arch Biochem Biophys       Date:  1998-06-15       Impact factor: 4.013

View more
  45 in total

Review 1.  The complications of promiscuity: endocannabinoid action and metabolism.

Authors:  S P H Alexander; D A Kendall
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

2.  'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors.

Authors:  W-S V Ho; D A Barrett; M D Randall
Journal:  Br J Pharmacol       Date:  2008-08-11       Impact factor: 8.739

3.  FABP-1 gene ablation impacts brain endocannabinoid system in male mice.

Authors:  Gregory G Martin; Sarah Chung; Danilo Landrock; Kerstin K Landrock; Huan Huang; Lawrence J Dangott; Xiaoxue Peng; Martin Kaczocha; Drew R Seeger; Eric J Murphy; Mikhail Y Golovko; Ann B Kier; Friedhelm Schroeder
Journal:  J Neurochem       Date:  2016-06-22       Impact factor: 5.372

Review 4.  Anandamide and vanilloid TRPV1 receptors.

Authors:  Ruth A Ross
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

5.  Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB₁ receptors and TRPV1 channels.

Authors:  Raffaele Capasso; Pierangelo Orlando; Ester Pagano; Teresa Aveta; Lorena Buono; Francesca Borrelli; Vincenzo Di Marzo; Angelo A Izzo
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

6.  Intracellular mechanisms of N-acylethanolamine-mediated neuroprotection in a rat model of stroke.

Authors:  P Garg; R S Duncan; S Kaja; P Koulen
Journal:  Neuroscience       Date:  2009-12-03       Impact factor: 3.590

7.  Female Mice are Resistant to Fabp1 Gene Ablation-Induced Alterations in Brain Endocannabinoid Levels.

Authors:  Gregory G Martin; Sarah Chung; Danilo Landrock; Kerstin K Landrock; Lawrence J Dangott; Xiaoxue Peng; Martin Kaczocha; Eric J Murphy; Ann B Kier; Friedhelm Schroeder
Journal:  Lipids       Date:  2016-07-23       Impact factor: 1.880

8.  Palmitoylethanolamide Reverses Paclitaxel-Induced Allodynia in Mice.

Authors:  Giulia Donvito; Jenny L Wilkerson; M Imad Damaj; Aron H Lichtman
Journal:  J Pharmacol Exp Ther       Date:  2016-09-08       Impact factor: 4.030

9.  Scp-2/Scp-x ablation in Fabp1 null mice differentially impacts hepatic endocannabinoid level depending on dietary fat.

Authors:  Gregory G Martin; Drew R Seeger; Avery L McIntosh; Sarah Chung; Sherrelle Milligan; Danilo Landrock; Lawrence J Dangott; Mikhail Y Golovko; Eric J Murphy; Ann B Kier; Friedhelm Schroeder
Journal:  Arch Biochem Biophys       Date:  2018-05-12       Impact factor: 4.013

10.  Actions of two naturally occurring saturated N-acyldopamines on transient receptor potential vanilloid 1 (TRPV1) channels.

Authors:  Luciano De Petrocellis; Constance J Chu; Aniello Schiano Moriello; Juliane C Kellner; J Michael Walker; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2004-08-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.